Institutional Ownership
Protagonist Therapeutics Inc
CUSIP 74366E102COMPTGXQ1 2026
Institutional Holders
316
13F filers
Shares Held
78.74M
Aggregate institutional
Institutional Value
$8.04B
Q1 2026
Net New Holders
+4
49 new · 45 closed
Institutional Ownership Trend
Aggregate 13F value by quarter
Multi-quarter trend — upgrade to see history
UpgradePosition Activity
Q1 2026
New positions49
Increased109
Decreased104
Sold out45
Institutional Holders
316 funds hold this security · Q1 2026
| # | Fund | Shares | Value | Δ Shares | Activity |
|---|---|---|---|---|---|
| 1 | Blackrock, Inc. | 9.78M | $1.03B | +63.4K | Added |
| 2 | Farallon Capital Management LLC | 6.35M | $669.17M | +6.35M | New |
| 3 | Ubs Group AG | 5.18M | $545.74M | +2.41M | Added |
| 4 | Rtw Investments, LP | 5.06M | $533.22M | 0 | Held |
| 5 | Wellington Management Group LLP | 3.60M | $379.40M | +428.2K | Added |
| 6 | Vanguard Portfolio Management LLC | 3.48M | $366.92M | +3.48M | First Filing |
| 7 | State Street Corp | 3.12M | $328.51M | −83.0K | Reduced |
| 8 | Janus Henderson Group PLC | 2.89M | $304.87M | +241.5K | Added |
| 9 | Vanguard Capital Management LLC | 2.81M | $295.74M | +2.81M | First Filing |
| 10 | Johnson & Johnson | 2.45M | $258.14M | 0 | Held |
306 more institutional holders on Premium
See every fund holding Protagonist Therapeutics Inc, with full quarter-over-quarter share changes.
Unlock all holders